Lindström Annika

Stäng

Kontakt

Landstinget Dalarna

Box 712 791 29 Falun 023-49 00 00 landstinget.dalarna@ltdalarna.se

Överläkare, Postdoc Forskningstjänst 50 % postdoc Centrum för Klinisk Forskning Dalarna.

Annika Lindström

Avhandling: Prognostic factors for squamous cell cervical cancer: tumor markers, hormones, smoking, and S-phase fraction.

Kliniskt verksam som privatpraktiserande läkare i Bjursås, Falu kommun, med samverkansavtal enligt nationella läkarvårdstaxan.

Specialistläkare: obstetrik – gynekologi 1987

Disputerade 2010, Gynekologisk Onkologi,
Institutionen för strålningsvetenskaper, Umeå Universitet.

Forskningsprojekt

Tidigare:
Prognostiska faktorer för invasiv cancer i livmoderhalsen.
Tumörmarkörer vid CIN och invasiv cervixcancer.

Behandling av ”Urethral Pain Syndrome” (UPS) hos kvinnor.

Nuvarande:
Undersökning av prevalens av högrisk humant papillomvirus (HR-HPV) samt utredning av förekomst av förstadier till cervixcancer hos kvinnor 60- 90 år.
Samarbete med Uppsala Universitet.

Medarbetare: Professor Matts Olovsson, Professor Ulf Gyllensten, PhD Inger Gustavsson Uppsala Universitet, Gynekolog Ruth Hermansson Onkologkliniken, Örebro.

Vetenskapliga publikationer

Urethral instillations of clobetasol propionate and lidocaine: a promising treatment of urethral pain syndrome 
Clin. Exp. Obstet. Gynecol. - ISSN: 0390-6663 XLIII, n. 6, 2016
doi: 10.12891/ceog3178.2016 

Immunohistochemical LRIG3 expression in cervical intraepithelial neoplasia and invasive squamous cell cervical cancer: association with expression of tumor markers, hormones, high-risk HPV-infection, smoking and patient outcome 
Eur J Histochem.
2014 Apr 15;58(2):2227. doi: 10.4081/ejh.2014.2227.

Correlation between LRIG1 and LRIG2 expressions and expression of 11 tumor markers, with special reference to tumor suppressors, in CIN and normal cervical epithelium.
Gynecol Oncol. 2011 May 30. [Epub ahead of print]

LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix
Acta Oncologica
Posted online on 16 Jun 2010.

Discrepancies in expression and prognostic value of tumor markers in adenocarcinoma and squamous cell carcinoma in cervical cancer.
Anticancer Res. 2009 Jul;29(7):2577-8.

LRIG1 and squamous epithelial uterine cervical cancer: correlation to prognosis, other tumor markers, sex steroid hormones, and smoking.
Int J Gynecol Cancer. 2008 Mar-Apr;18(2):312-7. Epub 2007 Jul 11

Associations between ten biological tumor markers in squamous cell cervical cancer and serum estradiol, serum progesterone and smoking.
Anticancer Res. 2007 May-Jun;27(3B):1401-6.

Predicting the outcome of squamous cell carcinoma of the uterine cervix using combinations of individual tumor marker expressions.
Anticancer Res. 2007 May-Jun;27(3B):1609-15.

Correlation between serum estradiol/progesterone ratio and survival length in invasive squamous cell cervical cancer.
Anticancer Res. 2005 Jan-Feb;25(1B):611-6.

Diagnostic, endocrinological, behavioral, and DNA ploidy differences between squamous cell and adenomatous carcinoma of the cervix uteri.
Oncol Res. 2004;14(7-8):321-4.

Correlations between serum progesterone and smoking, and the growth fraction of cervical squamous cell carcinoma.
Anticancer Res. 2000 Sep-Oct;20(5C):3637-40.

Avhandling:Prognostic factors for squamous cell cervical cancer: tumor markers, hormones, smoking, and S-phase fraction.